Clinical and Demographic Profile of Patients with Crohn's Disease in Specialized Hospital for Gastrointestinal and Liver Diseases and Surgery in Al-Najaf Province
DOI:
https://doi.org/10.46966/msjar.v5i3.228Keywords:
Crohn's Disease, Pharmacological Treatment, Biopsy, Endoscopy, Immunosuppressant'sAbstract
Background: Crohn’s disease (CD) It is a chronic inflammation that occurs in the digestive system. This disease is widespread in developing countries. Aim of study: To estimation the ratio of clinical and demographic data of CD patients at Specialized Hospital for Gastrointestinal and Liver Diseases and Surgery in AL- Najaf Province. Patients and Methods : Demographic and clinical data were obtained by medical analysis data to patients attended into Specialized Hospital for Gastrointestinal and Liver Diseases and Surgery in AL- Najaf Province from October 2022 to March 2024. Results: Sixty-four patients diagnosed with Crohn's disease participated in this study. The findings indicated that the majority of individuals infected with this disease were women, with the age group of 30 to 39 years being the most prevalent among the infected population. The findings indicate that freelancers and housewives are the most impacted by this disease. The results indicated that the majority of patients visiting the hospital are from Najaf Governorate. The disease was diagnosed through biopsy samples collected from different regions of the digestive system, and the treatment for the majority of patients involved immunosuppressant medications. Conclusions: Despite the increasing incidence, we highlight the Education and a extra intestinal manifestation in this study, and reflecting a high need for hospitalization and immune-modulatory, and uses biological treatment, , and surgery.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Ghadaq Hameed Neamah AL-Kefaei

This work is licensed under a Creative Commons Attribution 4.0 International License.
In submitting the manuscript to the Medical Science Journal for Advance Research, the authors certify that:
- They are authorized by their co-authors to enter into these arrangements.
- The work described has not been formally published before, except in the form of an abstract or as part of a published lecture, review, thesis, or overlay journal.
- That it is not under consideration for publication elsewhere,
- The publication has been approved by the author(s) and by responsible authorities – tacitly or explicitly – of the institutes where the work has been carried out.
- They secure the right to reproduce any material that has already been published or copyrighted elsewhere.
- They agree to the following license and copyright agreement.
License and Copyright Agreement
Authors who publish with Medical Science Journal for Advance Research agree to the following terms:
- Authors retain copyright and grant the Medical Science Journal for Advance Research right of first publication with the work simultaneously licensed under Creative Commons Attribution License (CC BY 4.0) that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors can enter into separate, additional contractual arrangements for the non-exclusive distribution of the Medical Science Journal for Advance Research published version of the work (e.g., post it to an institutional repository or edit it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) before and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.


















